Adoptive immunotherapy of malignancies
Shubina, I.Zh.; Bliumenberg, A.G.; Volkov, S.M.; Demidov, L.V.; Kiselevskiĭ, M.V.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2007(11): 9-15
2007
ISSN/ISBN: 0869-6047 PMID: 18080522 Document Number: 606324
The results of the studies show that mononuclear leukocytes isolated from human peripheral blood, malignant effusions, and surgically removed spleen can be generated into lymphokine-activated killers (LAK) characterized by high anti-tumor activity. LAKs may be used for adoptive immunotherapy of malignant effusions and the prevention of tumor recurrence in oncological patients after radical surgery.
Document emailed within 1 workday
Related Documents
Daĭkhes, N.A.; Davudov, K.S. 1996: Adoptive immunotherapy methods in ENT oncology Vestnik Otorinolaringologii 1: 35-38Yoshida, S.; Takai, N.; Saito, T.; Tanaka, R. 1987: Adoptive immunotherapy in patients with malignant glioma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1930-1932
Sarna, S.; Bhola, R.K. 1989: Adoptive immunotherapy of tumor in mice in combination with cyclophosphamide Archivum Immunologiae et Therapiae Experimentalis 37(5-6): 533-538
Li, P.S. 1993: The future application of adoptive immunotherapy in treatment of lung cancer Zhonghua Nei Ke Za Zhi 32(9): 579-580
Sekine, T.; Kakizoe, T.; Tobisu, K.; Takai, K.; Tanaka, Y.; Makuuchi, M.; Takayama, T. 1989: Cultivation of human tumor infiltrating lymphocytes for use in adoptive immunotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-2): 1469-1473
Yamasaki, T.; Kikuchi, H. 1989: An experimental approach to specific adoptive immunotherapy for malignant brain tumors Nihon Geka Hokan. Archiv für Japanische Chirurgie 58(6): 485-492
Semino, C.; Martini, L.; Queirolo, P.; Cangemi, G.; Costa, R.; Alloisio, A.; Ferlazzo, G.; Sertoli, M.R.; Reali, U.M.; Ratto, G.B.; Melioli, G. 1999: Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience Anticancer Research 19(6c): 5645-5649
Kikkawa, K. 1992: Adoptive immunotherapy of refractory pulmonary tuberculosis using sensitized autologous lymphocytes Kekkaku: 67(10): 684-686
Vaquero, J.; Martínez, R.; de Haro, J.; Barbolla, L.; Salazar, J.; Santos, H. 1987: Adoptive immunotherapy in glioblastoma multiforme: experience with the use of intrathecal infusions of autologous leukocytes Archivos de Neurobiologia 50(3): 183-190
Zanovello, P.; Rosato, A.; Bronte, V.; Cerundolo, V.; Collavo, D. 1991: Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins Annali Dell'istituto Superiore di Sanita 27(1): 91-95
Kubo, M.; Morisaki, T.; Kuroki, H.; Tasaki, A.; Yamanaka, N.; Matsumoto, K.; Nakamura, K.; Onishi, H.; Baba, E.; Katano, M. 2003: Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer Anticancer Research 23(6a): 4443-4449
Salup, R.R.; Toth, J.A.; Hiserodt, J.C.; Wolmark, N. 1987: Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes Progress in Clinical and Biological Research 244: 39-48
Chester, S.J.; Esparza, A.R.; Albala, M.M. 1975: Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy Cancer Research 35(3): 634-636
Takeda, T.; Watanabe, M.; Umeshita, K.; Goto, M.; Monden, M. 2004: Long-term prognosis of hepatocellular carcinoma patients treated with adoptive immunotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1646-1648
Nii, A.; Sone, S.; Okubo, A.; Fawzy, F.; Yanagawa, H.; Ogura, T. 1987: Lymphokine-activated killer (LAK) adoptive immunotherapy: optimal method for large-scale LAK induction Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 1): 1871-1876
Kanai, T.; Monden, M.; Takeda, T.; Gotoh, M.; Sakon, M.; Umeshita, K.; Hasuike, Y.; Sakita, I.; Nakano, H.; Yoshida, T. 1993: Adoptive immunotherapy in patients with multiple hepatic cancers using lymphokine activated killer cells (LAK) and interleukin-2 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(11): 1457-1460
Noto, T.; Tokuda, Y.; Tajima, T.; Mitomi, T.; Nakamura, Y.; Watanabe, K.; Yamamura, M.; Ichinohe, K. 1989: A new high-yield continuous cell culture system and its clinical application in adoptive immunotherapy with LAK cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-3): 1893-1898
Marcus, S.L.; Dutcher, J.P.; Paietta, E.; Ciobanu, N.; Strauman, J.; Wiernik, P.H.; Hutner, S.H.; Frank, O.; Baker, H. 1987: Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells Cancer Research 47(15): 4208-4212
Marincola, F.M.; Da Pozzo, L.F.; Drucker, B.J.; Holder, W.D. 1990: Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model Surgery 108(5): 919-929
Porter, D.L.; Roth, M.S.; Lee, S.J.; McGarigle, C.; Ferrara, J.L.; Antin, J.H. 1996: Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation Bone Marrow Transplantation 18(5): 975-980